QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - FRA:QIA - NL0015002CX3 - Common Stock
38.07 EUR
+0.31 (+0.83%)
We assign a fundamental rating of 6 out of 10 to QIA. QIA was compared to 18 industry peers in the Life Sciences Tools & Services industry. QIA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. QIA is not valued too expensively and it also shows a decent growth rate. This makes QIA very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QIA was profitable.
QIA had a positive operating cash flow in the past year.
Each year in the past 5 years QIA has been profitable.
QIA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QIA has a Return On Assets of 6.19%. This is in the better half of the industry: QIA outperforms 72.22% of its industry peers.
Looking at the Return On Equity, with a value of 11.11%, QIA is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
QIA has a Return On Invested Capital of 7.44%. This is in the better half of the industry: QIA outperforms 61.11% of its industry peers.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is significantly below the industry average of 13.84%.
The last Return On Invested Capital (7.44%) for QIA is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
Looking at the Profit Margin, with a value of 19.58%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of QIA has declined.
Looking at the Operating Margin, with a value of 27.02%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of QIA has grown nicely.
QIA has a better Gross Margin (64.10%) than 94.44% of its industry peers.
QIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QIA is destroying value.
QIA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, QIA has less shares outstanding
Compared to 1 year ago, QIA has an improved debt to assets ratio.
2.2 Solvency
QIA has an Altman-Z score of 3.41. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.41, QIA is doing good in the industry, outperforming 61.11% of the companies in the same industry.
QIA has a debt to FCF ratio of 4.50. This is a neutral value as QIA would need 4.50 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.50, QIA is doing good in the industry, outperforming 72.22% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
QIA's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. QIA outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.41 |
ROIC/WACC0.94
WACC7.9%
2.3 Liquidity
A Current Ratio of 2.60 indicates that QIA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.60, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA's Quick ratio of 2.30 is amongst the best of the industry. QIA outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.62%, which is quite good.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
Looking at the last year, QIA shows a small growth in Revenue. The Revenue has grown by 5.32% in the last year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
QIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.80% yearly.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.89% yearly.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.66, the valuation of QIA can be described as rather expensive.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than 72.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of QIA to the average of the S&P500 Index (25.46), we can say QIA is valued slightly cheaper.
The Price/Forward Earnings ratio is 17.00, which indicates a correct valuation of QIA.
QIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 66.67% of the companies in the same industry.
QIA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.66 | ||
| Fwd PE | 17 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIA is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 72.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.25 | ||
| EV/EBITDA | 12.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.18
PEG (5Y)2.22
EPS Next 2Y8.08%
EPS Next 3Y8.5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.56%, QIA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.74, QIA pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.56, QIA pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
FRA:QIA (11/19/2025, 7:00:00 PM)
38.07
+0.31 (+0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.25B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target44.65 (17.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.26%
PT rev (3m)0.94%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-1.53%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.66 | ||
| Fwd PE | 17 | ||
| P/S | 4.62 | ||
| P/FCF | 20.25 | ||
| P/OCF | 14.55 | ||
| P/B | 2.62 | ||
| P/tB | 11.99 | ||
| EV/EBITDA | 12.8 |
EPS(TTM)2.04
EY5.36%
EPS(NY)2.24
Fwd EY5.88%
FCF(TTM)1.88
FCFY4.94%
OCF(TTM)2.62
OCFY6.87%
SpS8.24
BVpS14.52
TBVpS3.17
PEG (NY)2.18
PEG (5Y)2.22
Graham Number25.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.41 |
F-Score8
WACC7.9%
ROIC/WACC0.94
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QIA.DE FAQ
What is the fundamental rating for QIA stock?
ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.
What is the valuation status of QIAGEN N.V. (QIA.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.
How profitable is QIAGEN N.V. (QIA.DE) stock?
QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.
What is the valuation of QIAGEN N.V. based on its PE and PB ratios?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 18.66 and the Price/Book (PB) ratio is 2.62.
How financially healthy is QIAGEN N.V.?
The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.